NOVONIX Limited filings document foreign-issuer reporting for an ADR-listed battery materials and technology company. Its Form 6-K reports furnish ASX announcements, operating and financial results, material-event disclosures, material agreements, shareholder voting matters, and governance updates.
Company filings also record capital-structure activity such as applications for quotation of ordinary fully paid shares, notifications of unquoted equity securities, employee incentive performance rights, and director interest notices. These disclosures connect NOVONIX's public reporting with its ordinary shares, American depositary shares, incentive securities, and governance obligations as an Australian issuer with U.S. reporting.
NOVONIX Ltd director and Chief Executive Officer Michael O'Kronley reported his existing derivative holdings in the form of performance rights. These rights relate to 5,862,567 underlying ordinary shares, have an exercise price of $0.0000, become exercisable on December 31, 2028, and expire on December 31, 2029. The entry is recorded as a holding, with no buy or sell transaction reported.
Novonix Limited filed a Form 6-K that includes an ASX Appendix 3Y detailing a change in director interests for Michael O’Kronley. The filing records the issue of performance rights to the director following shareholder approval at the AGM held on 15 April 2026.
After this change, Michael O’Kronley holds 9,586,538 performance rights. The notice also confirms that the interests were not traded during a closed period, so no special trading clearance was required.
Novonix Limited reported the issue of 5,862,567 unquoted NVXAD performance rights on May 5, 2026 under an employee incentive scheme. These rights were issued to key management personnel member Michael O'Kronley and are not intended to be quoted on ASX.
After this grant, Novonix has 861,442,940 NVX ordinary fully paid shares on issue, 35,021,775 NVXAD performance rights, 14,016,667 NVXAA options and 45,221,586 NVXAL convertible notes outstanding. The issue relied on exception 13 in ASX Listing Rule 7.2, so did not require separate security holder approval.
NOVONIX Limited has completed the sale of its NOVONIX Battery Technology Solutions Inc. (BTS) business in Nova Scotia, Canada to former CEO Dr. Chris Burns. The divestiture is framed as part of a strategy to focus on building a vertically integrated synthetic graphite supply chain in North America.
Key terms include a share equity sale of the BTS business, including all related assets and liabilities, for a transaction price of US$1.00. As part of the deal, NOVONIX receives a 15% equity stake in the cathode business that will operate as Dryve Battery Materials Inc., while the cash balance at BTS as of closing is targeted at US$2 million, subject to agreed adjustments.
Post-transaction, BTS is split into two independent companies: Avrion Battery Labs Inc., providing advanced battery testing and R&D services, and Dryve Battery Materials Inc., advancing a patented pCAM-free dry synthesis platform for lithium-ion cathode materials. NOVONIX will also provide certain transition services and grant the buyer a trademark license through 31 December 2026.
NOVONIX Limited reports key strategic and cash developments for the quarter ended 31 March 2026. The U.S. Government certified the company’s Riverside project for a previously allocated US$103 million Section 48C advanced manufacturing tax credit, expected when the first 11,000 tonnes per annum of capacity is placed in service before 7 April 2028, with credits that can be sold to a third party.
NOVONIX signed a binding term sheet to divest its Battery Technology Solutions business while retaining a 15% equity stake, and secured exclusive rights to evaluate buying adjacent Riverside land for US$26.5 million, a move the company says could enable more than US$200 million in potential capital savings if a 50,000 tpa build-out is consolidated on one site. The company also highlighted revised mass production timing for Panasonic Energy to the second half of 2027 and a changing U.S. trade environment for anode materials.
Financially, NOVONIX posted a quarterly operating cash outflow of US$14.4 million and invested US$6.8 million in property, plant, and equipment, mainly at Riverside. Cash and cash equivalents were US$57.1 million at quarter-end, equating to an estimated 4.0 quarters of funding based on recent cash usage. The company also received notice from Nasdaq that its ADRs no longer meet the US$1.00 minimum bid price requirement and is assessing options such as adjusting the ADR-to-ordinary share ratio.
NOVONIX Limited has issued 546,279 unquoted NVXAD performance rights under its employee incentive scheme, with these rights ranking equally with existing securities in that class. None of the new rights were issued to key management personnel or their associates.
After this grant, NOVONIX has 861,442,940 NVX ordinary fully paid shares on issue. Its unquoted securities on issue include 29,159,208 NVXAD performance rights, 14,016,667 NVXAA options expiring on various dates at various prices, 1,008,567 NVXAB share rights and 45,221,586 NVXAL convertible notes. The issue was made under exception 13 of ASX Listing Rule 7.2, so it did not require separate security holder approval under Listing Rule 7.1.
Novonix Limited is reporting the issue and ASX quotation of additional ordinary fully paid shares resulting from the conversion of performance rights under an employee incentive scheme. The new shares are in an existing quoted class and will rank equally with other ordinary shares from their issue date.
No cash is being paid for these shares, with the consideration valued at approximately AUD 0.265 per share. Following this quotation, Novonix states that its quoted ordinary share capital on ASX will comprise 861,442,940 ordinary fully paid shares, alongside several unquoted classes including performance rights, options and convertible notes.
NOVONIX Limited filed an amended Form 6-K to correct formatting in its previously furnished AGM presentation, confirming no substantive changes to the underlying content. The filing also provides the Chairman’s address, updated strategy, and detailed voting results from the April 15, 2026 Annual General Meeting.
The Chairman highlights 2025 as a key year, including delivery of the first mass-production, commercial-grade synthetic graphite sample and installation of four graphitization furnaces at the Riverside facility in Chattanooga to support Panasonic Energy qualification. NOVONIX expects mass production of industrial-grade synthetic graphite to begin in 2026 and now anticipates mass production of battery-grade anode material for Panasonic Energy in the second half of 2027.
The company executed a funding agreement with Yorkville Advisors for access to US$100 million in convertible debentures, sold its Mt Dromedary natural graphite project, and agreed a binding term sheet to divest its Battery Technology Solutions division while retaining 15% ownership. NOVONIX reports contracted offtakes including a four‑year, 10,000‑tonne commitment and a five‑year, minimum 32,000‑tonne commitment, both subject to successful qualification. All AGM resolutions, including director re‑elections, performance rights, share rights, and additional 10% placement capacity, were carried by strong majorities.
Novonix Limited filed a Form 6-K furnishing an ASX Appendix 3Z Final Director’s Interest Notice. The notice states that director Nick Liveris ceased to be a director on 15 April 2026, with the last notice dated 16 March 2026. The form is an administrative disclosure of his final director interests, and the section for securities held as registered holder shows no detailed entries.
NOVONIX Limited provides an update from its Annual General Meeting, outlining progress toward large-scale U.S. synthetic graphite production and confirming all AGM resolutions passed by poll. The company has installed four graphitization furnaces at its Chattanooga Riverside facility and delivered its first mass production, commercial-grade synthetic graphite sample for industrial uses in 2025. NOVONIX expects mass production of industrial-grade synthetic graphite to start in 2026 and now anticipates mass production of battery-grade anode material for Panasonic Energy in the second half of 2027, following rigorous qualification processes. It has invested about $200 million in Chattanooga operations and is planning expansion to 50,000 tonnes per annum, with potential capital savings of more than $200 million if capacity is consolidated on one site. Funding support includes a $100 million convertible debenture facility with Yorkville Advisors, a $100 million CMEI grant for Riverside, and a $754 million conditionally committed DOE loan to support future capacity. NOVONIX holds binding offtake commitments totaling 10,000 tonnes over four years and at least 32,000 tonnes over five years, subject to product qualification, and continues discussions with additional customers while also divesting non-core assets to focus on U.S. synthetic graphite.